arrow
M

Martina Rudelius

Institute of Pathology
H指数:41
被引数:5,741

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Leukocytosis, monocytosis, and eosinophilia in systemic mastocytosis: analysis of phenotype, genetics and prognosis in 596 patients from the GREM registry

系统性肥大细胞增生症中的白细胞增多、单核细胞增多和嗜酸性粒细胞增多:对GREM登记研究中596例患者的表型、遗传学和预后分析

2025-09-240
PREAI
PUMA-induced apoptosis drives bone marrow failure and genomic instability in telomerase-deficient mice

PUMA诱导的细胞凋亡导致端粒酶缺陷小鼠的骨髓衰竭和基因组不稳定性

2025-08-190
OA
Hyperreactive B cells instruct their elimination by T cells to curb autoinflammation and lymphomagenesis

高反应性B细胞通过T细胞介导的清除来抑制自身炎症和淋巴瘤发生。

IMMUNITY
IF26.3
2025-01-010
OAAI
CXCR4-directed endoradiotherapy with [177Lu]Pentixather added to total body irradiation for myeloablative conditioning in patients with relapsed/refractory acute myeloid leukemia

CXCR4靶向内放射治疗联合[177Lu]Pentixather用于大剂量骨髓清除性预处理,治疗复发/难治性急性髓系白血病患者

2025-01-012
PRE
The new WHO 2022 and ICC proposals for the classification of myelodysplastic neoplasms. Validation based on the Düsseldorf MDS Registry and proposals for a merged classification
LEUKEMIA
IF13.4
2024-01-234
OAAI
A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich
2023-08-187
OAAI
Suppression of SARS-CoV-2 Replication with Stabilized and Click-Chemistry Modified siRNAs

用稳定和点击化学修饰的sirna抑制SARS-CoV-2复制

2022-08-1210
OA
PARP14 is a novel target in STAT6 mutant follicular lymphoma

PARP14是STAT6突变型滤泡性淋巴瘤的新靶点

LEUKEMIA
IF13.4
2022-07-1810
OAAI
The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma
2021-03-0143
OAAI